Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
145.10
+2.57 (1.80%)
At close: Sep 5, 2025, 4:00 PM
145.00
-0.10 (-0.07%)
After-hours: Sep 5, 2025, 7:50 PM EDT
Insmed Stock Forecast
Stock Price Forecast
The 16 analysts that cover Insmed stock have a consensus rating of "Strong Buy" and an average price target of $142.38, which forecasts a -1.87% decrease in the stock price over the next year. The lowest target is $101 and the highest is $240.
Price Target: $142.38 (-1.87%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 9 | 9 | 9 |
| Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 17 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $140 → $171 | Buy | Maintains | $140 → $171 | +17.85% | Sep 3, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $126 → $144 | Hold | Maintains | $126 → $144 | -0.76% | Aug 21, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $111 → $135 | Buy | Maintains | $111 → $135 | -6.96% | Aug 20, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 20, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $126 → $139 | Strong Buy | Maintains | $126 → $139 | -4.20% | Aug 14, 2025 |
Financial Forecast
Revenue This Year
481.79M
from 363.71M
Increased by 32.47%
Revenue Next Year
1.09B
from 481.79M
Increased by 126.03%
EPS This Year
-5.60
from -5.57
EPS Next Year
-3.55
from -5.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 523.1M | 1.5B | |||
| Avg | 481.8M | 1.1B | |||
| Low | 432.3M | 837.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 43.8% | 206.6% | |||
| Avg | 32.5% | 126.0% | |||
| Low | 18.9% | 73.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.19 | -2.49 | |||
| Avg | -5.60 | -3.55 | |||
| Low | -5.81 | -5.46 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.